Mingyan Zhao

2.5k total citations
63 papers, 1.5k citations indexed

About

Mingyan Zhao is a scholar working on Molecular Biology, Infectious Diseases and Neurology. According to data from OpenAlex, Mingyan Zhao has authored 63 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 17 papers in Infectious Diseases and 11 papers in Neurology. Recurrent topics in Mingyan Zhao's work include COVID-19 Clinical Research Studies (15 papers), Long-Term Effects of COVID-19 (11 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). Mingyan Zhao is often cited by papers focused on COVID-19 Clinical Research Studies (15 papers), Long-Term Effects of COVID-19 (11 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). Mingyan Zhao collaborates with scholars based in China, Saudi Arabia and New Zealand. Mingyan Zhao's co-authors include Kai Kang, Shangha Pan, Lei Jiang, Xianglin Meng, Mingran Zhao, Hongchi Jiang, Xueying Sun, Gang Tan, Jingfeng Gao and Dongsheng Fei and has published in prestigious journals such as PLoS ONE, The Science of The Total Environment and Water Research.

In The Last Decade

Mingyan Zhao

60 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingyan Zhao China 22 499 226 214 192 177 63 1.5k
Tammy R. Dugas United States 25 363 0.7× 382 1.7× 117 0.5× 92 0.5× 151 0.9× 63 2.1k
Norbert Weiss Germany 22 370 0.7× 125 0.6× 132 0.6× 31 0.2× 315 1.8× 68 2.1k
Seok Joon Shin South Korea 28 738 1.5× 78 0.3× 335 1.6× 63 0.3× 262 1.5× 89 2.6k
Krithika Lingappan United States 25 559 1.1× 91 0.4× 166 0.8× 77 0.4× 732 4.1× 68 2.0k
Franz Tatzber Austria 28 467 0.9× 99 0.4× 194 0.9× 55 0.3× 116 0.7× 69 2.3k
Sebastián Mas Spain 25 948 1.9× 63 0.3× 348 1.6× 55 0.3× 169 1.0× 73 2.8k
Sail Chun South Korea 23 287 0.6× 64 0.3× 215 1.0× 91 0.5× 121 0.7× 158 1.8k
Hye Eun Yoon South Korea 23 424 0.8× 30 0.1× 266 1.2× 114 0.6× 295 1.7× 110 2.1k
Cai‐Mei Zheng Taiwan 25 323 0.6× 42 0.2× 115 0.5× 136 0.7× 133 0.8× 86 1.4k
Pablo Castro Chile 28 708 1.4× 47 0.2× 276 1.3× 168 0.9× 221 1.2× 133 2.5k

Countries citing papers authored by Mingyan Zhao

Since Specialization
Citations

This map shows the geographic impact of Mingyan Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingyan Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingyan Zhao more than expected).

Fields of papers citing papers by Mingyan Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingyan Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingyan Zhao. The network helps show where Mingyan Zhao may publish in the future.

Co-authorship network of co-authors of Mingyan Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Mingyan Zhao. A scholar is included among the top collaborators of Mingyan Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingyan Zhao. Mingyan Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Pengfei, Yanqi Liu, Nana Li, et al.. (2025). Causal relationship between gut microbiota and pneumonia: a Mendelian randomization and retrospective case–control study. BMC Pulmonary Medicine. 25(1). 449–449.
2.
Wang, Jianpeng, Yuan Xiong, Yuan Gao, et al.. (2025). Point-annotation supervision for robust 3D pulmonary infection segmentation by CT-based cascading deep learning. Computers in Biology and Medicine. 187. 109760–109760. 2 indexed citations
3.
Zhang, Weiting, et al.. (2024). Comparison of the therapeutic effect of Paxlovid and Azvudine in the treatment of COVID-19: A retrospective study. Journal of Infection and Public Health. 17(12). 102583–102583. 1 indexed citations
5.
Peng, Yahui, Changsong Wang, Hongliu Cai, et al.. (2024). Reduced Viral Shedding Time in High-Risk COVID-19 Patients Infected by Omicron and Treated with Paxlovid: A Real-World Study from China. Infection and Drug Resistance. Volume 17. 1267–1279. 1 indexed citations
6.
7.
Zhang, Jiannan, Rui Gong, Yiqi Wang, et al.. (2024). Critical Role of S100A9 in Sepsis-associated Acute Kidney Injury: Mechanistic Insights through Pyroptosis Pathway Modulation. Inflammation. 48(4). 1879–1899. 4 indexed citations
8.
9.
Guo, Yi, et al.. (2023). Mitigating the inhibition of antibacterial agent chloroxylenol on nitrification system-The role of Rhodococcus ruber in a bioaugmentation system. Journal of Hazardous Materials. 447. 130758–130758. 21 indexed citations
10.
Cao, Yanhui, Guodong Sun, Dongsheng Fei, et al.. (2023). CircPTP4A2 Promotes Microglia Polarization in Cerebral Ischemic Stroke via miR-20b-5p/YTHDF1/TIMP2 Axis. NeuroMolecular Medicine. 25(4). 501–515. 5 indexed citations
11.
Yang, Wei, Lei Wang, Yuxin Zhou, et al.. (2022). Clinical characteristics of 310 SARS-CoV-2 Omicron variant patients and comparison with Delta and Beta variant patients in China. Virologica Sinica. 37(5). 704–715. 27 indexed citations
12.
Yang, Xianghong, Renhua Sun, Mingyan Zhao, et al.. (2020). Expert recommendations for blood purification protocol in patients with severe COVID-19. Zhonghua yixue zazhi. 100. 2 indexed citations
14.
Gao, Yang, Changsong Wang, Kai Kang, et al.. (2020). Cytokine Storm May Not Be the Chief Culprit for the Deterioration of COVID-19. Viral Immunology. 34(5). 336–341. 12 indexed citations
15.
Yang, Xianghong, Bo Hu, You Shang, et al.. (2020). Expert consensus on management of analgesia and sedation for patients with severe coronavirus disease 2019. Chinese Medical Journal. 133(18). 2186–2188.
16.
Wu, Xiaoke, Kaijiang Yu, Yongchen Wang, et al.. (2020). The Efficacy and Safety of Triazavirin for COVID-19: A Trial Protocol. Engineering. 6(10). 1199–1204. 14 indexed citations
17.
Jiang, Lei, Lei Zhang, Kai Kang, et al.. (2016). Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation. Biomedicine & Pharmacotherapy. 84. 130–138. 118 indexed citations
18.
Tan, Gang, Shangha Pan, Jie Li, et al.. (2011). Hydrogen Sulfide Attenuates Carbon Tetrachloride-Induced Hepatotoxicity, Liver Cirrhosis and Portal Hypertension in Rats. PLoS ONE. 6(10). e25943–e25943. 125 indexed citations
19.
Kang, Kai, Hongchi Jiang, Mingyan Zhao, Xueying Sun, & Shangha Pan. (2010). [Protection of CSE/H2S system in hepatic ischemia reperfusion injury in rats].. PubMed. 48(12). 924–8. 7 indexed citations
20.
Kang, Kai, Mingyan Zhao, Hongchi Jiang, et al.. (2009). Role of hydrogen sulfide in hepatic ischemia-reperfusion–induced injury in rats. Liver Transplantation. 15(10). 1306–1314. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026